Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis (Q38792200)

6 September 2017

0 references

1 reference

title

Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis (English)

1 reference

6 September 2017

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

Tahir M. Khan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

Miqdad Asaria

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

Oliver Pfaar

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

Cemal Cingi

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

Susanne Halken

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

Peter W Hellings

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

Edward Frank Knol

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

Désirée E. Larenas-Linnemann

10 June 2020

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

Martin Penagos

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

Constantinos Pitsios

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

Olympia Tsilochristou

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

Carsten B Schmidt-Weber

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

15

S Durham

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

author name string

U Nurmatov

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

S Arasi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

H Zaman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

A Agarwal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

G Netuveli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

G Roberts

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

A Muraro

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

I J Ansotegui

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

M Calderon

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

R Gerth van Wijk

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

E Hamelmann

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

L Jacobsen

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

S Lin

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

P Maggina

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

R Mösges

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

H Oude Elberink

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

G Pajno

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

R Panwankar

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

E Pastorello

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

G Rotiroti

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

F Timmermans

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

E-M Varga

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

J Wilkinson

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

A Williams

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

M Worm

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

L Zhang

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

A Sheikh

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

language of work or name

1 reference

11 May 2017

1 reference

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

1597-1631

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: a global synthesis

10 June 2020

cites work

1 reference

Changing prevalence of wheeze, rhinitis and allergic sensitisation in late childhood: findings from 2 Isle of Wight birth cohorts 12 years apart

21 January 2018

1 reference

World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

21 January 2018

1 reference

Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis

21 January 2018

1 reference

Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study

21 January 2018

1 reference

The work impact of asthma and rhinitis: findings from a population-based survey

21 January 2018

1 reference

Rhinitis as an independent risk factor for adult-onset asthma

21 January 2018

1 reference

GA² LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma

21 January 2018

1 reference

Immunotherapy for allergic rhinitis.

21 January 2018

1 reference

Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Asso

21 January 2018

1 reference

Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?

21 January 2018

1 reference

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review.

21 January 2018

1 reference

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

Immunotherapy with depigmented glutaraldehyde-polymerized extracts: changes in quality of life

21 January 2018

1 reference

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy

21 January 2018

1 reference

The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study.

21 January 2018

1 reference

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid

21 January 2018

1 reference

Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract

21 January 2018

1 reference

Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects

21 January 2018

1 reference

Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid

21 January 2018

1 reference

A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections

21 January 2018

1 reference

Long-term clinical efficacy of grass-pollen immunotherapy

21 January 2018

1 reference

A single dose desensitization for summer hay fever

21 January 2018

1 reference

Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis

21 January 2018

1 reference

A double-blind, placebo-controlled trial of polymerized whole ragweed for immunotherapy of ragweed allergy.

21 January 2018

1 reference

Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells

21 January 2018

1 reference

Negative clinical results from a randomised, double-blind, placebo-controlled trial evaluating the efficacy of two doses of immunologically enhanced, grass subcutaneous immunotherapy despite dose-dependent immunological response.

21 January 2018

1 reference

A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocol

21 January 2018

1 reference

Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children.

21 January 2018

1 reference

Clinical and immunologic evaluation of glutaraldehyde-modified tyrosine-adsorbed short ragweed extract: a double-blind, placebo-controlled trial

21 January 2018

1 reference

A double-blind, placebo-controlled study of immunotherapy with an alginate-conjugated extract of Parietaria judaica in patients with Parietaria hay fever

21 January 2018

1 reference

Clinical and immunological effects of immunotherapy with alum-absorbed grass allergoid in grass-pollen-induced hay fever

21 January 2018

1 reference

Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study.

21 January 2018

1 reference

Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.

21 January 2018

1 reference

A randomized placebo‐controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy*

21 January 2018

1 reference

Effect of grass pollen immunotherapy with Alutard SQ on quality of life in seasonal allergic rhinoconjunctivitis.

21 January 2018

1 reference

Enzyme potentiated desensitisation in treatment of seasonal allergic rhinitis: double blind randomised controlled study

21 January 2018

1 reference

A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma

21 January 2018

1 reference

Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis

21 January 2018

1 reference

Perennial is more effective than preseasonal subcutaneous immunotherapy in the treatment of seasonal allergic rhinoconjunctivitis

21 January 2018

1 reference

Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs

21 January 2018

1 reference

Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial

21 January 2018

1 reference

Efficacy of sublingual specific immunotherapy in Cupressaceae allergy using an extract of Cupressus arizonica. A double blind study

21 January 2018

1 reference

Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial

21 January 2018

1 reference

Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study

21 January 2018

1 reference

Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis

21 January 2018

1 reference

House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis

21 January 2018

1 reference

Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study

21 January 2018

1 reference

Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy

21 January 2018

1 reference

Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis

21 January 2018

1 reference

Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.

21 January 2018

1 reference

Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis

21 January 2018

1 reference

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis

21 January 2018

1 reference

Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis

21 January 2018

1 reference

Sublingual-swallow immunotherapy with standardized 3-grass pollen extract: a double-blind, placebo-controlled study

21 January 2018

1 reference

Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial

21 January 2018

1 reference

Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis

21 January 2018

1 reference

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

21 January 2018

1 reference

Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage

21 January 2018

1 reference

Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet

21 January 2018

1 reference

Sustained effect of SQ-standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life

21 January 2018

1 reference

Effects on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children monosensitized to mites

21 January 2018

1 reference

SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms

21 January 2018

1 reference

A randomized double-blind comparative study of sublingual immunotherapy for cedar pollinosis.

21 January 2018

1 reference

Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study

21 January 2018

1 reference

Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate

21 January 2018

1 reference

Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trial

21 January 2018

1 reference

Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both.

21 January 2018

1 reference

Modulation of mucosal/systemic antibody response after sublingual immunotherapy in mite-allergic children

21 January 2018

1 reference

A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.

21 January 2018

1 reference

A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract

21 January 2018

1 reference

Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization

21 January 2018

1 reference

Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study.

21 January 2018

1 reference

Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis.

21 January 2018

1 reference

Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.

21 January 2018

1 reference

Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections

21 January 2018

1 reference

Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score

21 January 2018

1 reference

A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis.

21 January 2018

1 reference

Cost-effectiveness of GRAZAX for prevention of grass pollen induced rhinoconjunctivitis in Southern Europe

21 January 2018

1 reference

Cost-effectiveness of grass allergen tablet (GRAZAX) for the prevention of seasonal grass pollen induced rhinoconjunctivitis - a Northern European perspective

21 January 2018

1 reference

Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost

21 January 2018

1 reference

Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany

21 January 2018

1 reference

Cost-effectiveness of grass pollen SCIT compared with SLIT and symptomatic treatment

21 January 2018

1 reference

Economic evaluation of 5-grass pollen tablets versus placebo in the treatment of allergic rhinitis in adults

21 January 2018

1 reference

Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma

21 January 2018

1 reference

Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany.

21 January 2018

1 reference

Economic evaluation of sublingual vs subcutaneous allergen immunotherapy

21 January 2018

1 reference

Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma

21 January 2018

1 reference

Economic evaluation of sublingual immunotherapy vs. symptomatic treatment in allergic asthma

21 January 2018

1 reference

Safety of a rush immunotherapy build-up schedule with depigmented polymerized allergen extracts

21 January 2018

1 reference

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper

21 January 2018

1 reference

Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ALL.13201

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28493631 AND SRC:MED&resulttype=core&format=json

10 June 2020

1 reference